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LETTERS TO THE EDITOR
All Allusions to the Great War Aside . . .
All allusions to the Great War aside, Miller (1) defends the value
of perfusion scintigraphy for risk stratification in patients with
coronary artery disease (CAD) in an editorial comment on the
Intermediate Lesions: Intracoronary Flow Assessment versus
99mTc-MIBI SPECT (ILIAS) study. The ILIAS was a Dutch
multicenter study designed as a direct comparison between perfu-
sion scintigraphy and intracoronary Doppler flow measurements
for clinical decision making in patients with intermediate coronary
lesions in the presence of multivessel disease (2). The patients were
included following a diagnostic catheterization that documented
multivessel CAD with one severe coronary narrowing, eligible for
percutaneous transluminal coronary angioplasty (PTCA), and one
intermediate lesion. A perfusion scintigraphy stress test was
considered mandatory for evaluation of the intermediate lesion in
those patients already scheduled for PTCA of the severe coronary
narrowing.
The results of the ILIAS trial show that it is safe to defer an
angioplasty of the intermediate lesions if the coronary flow velocity
reserve is above 2.0. This finding accords with previous small-sized
single-center experiences. Moreover, the Doppler flow measure-
ments appeared to be a better predictor for the occurrence of major
adverse cardiac events (i.e., the need for coronary revascularization)
related to the intermediate lesion than perfusion scintigraphy. This
latter finding is relevant for daily clinical practice in interventional
cardiology concerning decision making in intermediate coronary
narrowings. It may avoid the need for additional scintigraphic
stress testing following diagnostic procedures and facilitates ad hoc
PTCA.
Miller’s editorial (1) underscores the contribution of perfusion
scintigraphy for risk stratification in patients with CAD—that is,
patients with large-sized perfusion defects have a worse clinical
outcome compared to patients with smaller-sized perfusion defects
(3). These studies indicated that global assessment of myocardial
perfusion yields prognostic information. However, this is not in
contrast with the findings of the ILIAS trial, which demon-
strated the value of intracoronary physiologic parameters for
evaluation of regional myocardial perfusion (2). This latter
finding relates presumably to the difficulty to allocate reversible
perfusion defects to vascular territories, whereas intracoronary
measurements allow selective evaluation distal to coronary
narrowings. Miller’s conclusion (1) is correct, namely that it
would have been a physiological bridge too far if the contribu-
tion of intracoronary evaluation of coronary narrowings mea-
surements was interpreted to replace perfusion scintigraphy for
risk stratification. The ILIAS trial provides complementary
information relevant for clinical decision making in patients
already scheduled for cardiac catheterization. The contribution
of intracoronary physiologic testing should be considered as a
bridge (rather than a bridge too far) between noninvasive stress
testing providing prognostic information in patients with mul-
tivessel disease, and appropriate use of percutaneous interven-
tions based on accurate invasive evaluation of regional myocar-
dial perfusion.
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Coronary Microvascular Spasm in
Patients With Vasospastic Angina
I read with interest the study by Sun et al. (1), which showed that
25.5% of patients with vasospastic angina developed myocardial
ischemia with submaximal doses of intracoronary acetylcholine;
angina was unassociated with spasm of epicardial arteries and was
attributed to microvascular spasm. Remaining patients developed
myocardial ischemia only when epicardial spasm occurred, and Sun
et al. (1) did not rule out the coexistence of microvascular spasm in
these cases.
The Sun et al. (1) study is in keeping with the spasm of
resistance vessel (S-RV) concept of ischemic heart disease (IHD)
(2–5), which asserts that S-RV induces symptoms in all syndromes
of IHD and in cases with and without coronary artery disease
(CAD). S-RV is used instead of microvascular spasm, as spasm
probably occurs in vessels designed to undergo vasomotion to
maintain vascular homeostasis. The concept asserts that risk factors
act additively and operate by favoring S-RV, and there is evidence
that major risk factors favor S-RV—including hypercholesterol-
emia and CAD (2,4,5). The concept avers that stenotic CAD
favors S-RV through ischemia-induced S-RV, and there is abun-
dant evidence that significant ischemia favors S-RV (2,5). As an
example, effort angina is attributed to stenotic CAD plus exertion,
which together cause sufficient ischemia to trigger ischemia-
induced S-RV and clinical symptoms.
Interest in S-RV in IHD has been limited mainly to vasospastic
angina, as these cases are unassociated with stenotic CAD. But
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there is evidence for S-RV in stable angina (3,5), and relative
insufficiency probably is an invalid mechanism; cholesterol- and
stress-reduction significantly improved angina in a month’s time
(6), long before CAD could be improved—a finding incompatible
with classic relative insufficiency (3,5). Favorable to the concept,
cholesterol reduction favors vasodilation and can improve vasodi-
lation in one month (7) and, as stress can cause S-RV (3),
stress-reduction reasonably is vasodilative. Also, while plaque
rupture/thromboses are the accepted mechanisms of acute coro-
nary syndromes, a recent analysis showed significant faults with
this mechanism (5). For example, studies of infarction showing
rising incidences of thromboses over time are incompatible with
primary thromboses. If thromboses cause infarction, how can their
incidence increase over time? And recognition of S-RV during
ischemic episodes in unstable angina (8) is consistent with the
S-RV cause of this angina.
The S-RV concept offers an explanation for the only occasional
occurrence of vasospastic angina, and a viable explanation should
help establish the reasonableness of the concept. As vasospastic
angina is unassociated with CAD, this major vasoconstrictive
force is absent, and angina occurs only when there are high
levels of other risk factors as stress, gender and genetic factors,
etc.—which occur only occasionally. In IHD associated with
CAD, symptoms are attributed to the risk factor of CAD plus
other risk factors such as stress; consistent with this, induced
stress can cause myocardial ischemia in individuals with stable
angina (9,10). Also, absence of IHD in many individuals with
severe CAD is explained by the relative absence of other risk
factors such as stress.
Although considerable evidence supports the standard position,
there appears to be sufficient contravening evidence for the S-RV
concept to prompt a comprehensive review of its positions.
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Thyroid Hormone and
Arrhythmogenic Activity
We read with great interest the study by Chen et al. (1) in a recent
issue of the Journal. The investigators report that thyroid hormone
changes the electrophysiologic activity of the pulmonary vein
cardiomyocytes, and they suggest that increased tri-iodothyronine-
induced automaticity and enhanced triggered activity may increase
the arrhythmogenic activity of cardiomyocytes in hyperthyroidism.
They conclude that this mechanism contributes to arrhythmogenic
activity of hyperthyroidism.
Hyperthyroidism is known to be an important risk factor in the
etiology of atrial fibrillation (AF)(2). In a large retrospective study
investigating an unselected, community-based population of older
persons (3), we could demonstrate that the prevalence of AF was
2.3% in subjects with normal values for serum thyrotropin, 13.8%
in patients with overt hyperthyroidism (both low serum thyro-
tropin values [0.03 mU/l] and elevated free tri-iodothyronine
and free thyroxine concentrations), and 12.7% in patients with
subclinical hyperthyroidism (low values of serum thyrotropin
[0.4 mU/l], and free tri-iodothyronine and free thyroxine con-
centrations within the normal range). The relative risk of AF in
subjects with subclinical hyperthyroidism, compared with those
with normal concentrations of serum thyrotropin, was 5.2 (95%
confidence interval [CI] 2.1–8.7, p  0.01). Thus, a low serum
thyrotropin concentration was associated with a more than five-
fold higher likelihood for the presence of AF, with no significant
difference between subclinical and overt hyperthyroidism.
Individuals with low serum concentrations of thyrotropin re-
gardless of concentrations of free tri-iodothyronine and free
thyroxine should be considered as a population at risk for the
development of AF (4). Thus, thyroid secretion needs not increase
much, if at all, and serum concentrations of free tri-iodothyronine
and free thyroxine can stay within normal values for AF to occur.
Moreover, when AF occurs, there is only rarely either concurrent
or subsequent overt hyperthyroidism, but it is more commonly
associated with subclinical hyperthyroidism (5). We consider this
topic important, because subclinical hyperthyroidism is, at all,
more common than overt hyperthyroidism among people over age
60 (5) and does not progress to overt hyperthyroidism in most
cases (6).
We agree with Chen et al. (1) that L-tri-iodothyronine-induced
increased automaticity and enhanced triggered activity may be one
mechanism that could increase the arrhythmogenic activity of
cardiomyocytes in overt hyperthyroidism. But it is obvious from
clinical data that mechanisms, other than those triggered by free
tri-iodothyronine and free thyroxine, are important in AF associ-
ated with low serum thyrotropin.
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